Aditi Dhir, MD, discusses ongoing efforts in epithelioid and synovial sarcoma.
Aditi Dhir, MD
Advertisement
Articles by Aditi Dhir, MD
Aditi Dhir, MD, discusses risk-based stratification in patients with epithelioid and synovial sarcoma.
Aditi Dhir, MD, discusses the challenges of diagnosing patients with sarcoma.
Aditi Dhir, MD, discusses modifying treatment for adults versus pediatric patients with epithelioid sarcoma.
Advertisement
Latest Updated Articles
Dr. Dhir on Risk-Based Stratification in Epithelioid and Synovial SarcomaPublished: February 10th 2021 | Updated:
Dr. Dhir on Modifying Treatment for Adults Versus Pediatric Patients With Epithelioid SarcomaPublished: January 6th 2021 | Updated:
Dr. Dhir on Diagnostic Challenges in SarcomaPublished: February 5th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
4
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
5